Search research articles
Contact Us
Filters
Showing results (871-880 of 889) with videos related to
Page
of 89
Sort By:
Cancer Research
|
November 26, 2024
A Potent, Selective, Small-Molecule Inhibitor of DHX9 Abrogates Proliferation of Microsatellite Instable Cancers with Deficient Mismatch Repair
Jennifer Castro, Matthew H Daniels, David Brennan, et al.
Journal of the American Geriatrics Society
|
March 25, 2018
A Person-Centered Approach to Poststroke Care: The COMprehensive Post-Acute Stroke Services Model
Cheryl D Bushnell, Pamela W Duncan, Sarah L Lycan, et al.
Oncotarget
|
April 23, 2016
Abnormal lipid processing but normal long-term repopulation potential of myc-/- hepatocytes
Lia R Edmunds, P Anthony Otero, Lokendra Sharma, et al.
Circulation. Cardiovascular Quality and Outcomes
|
June 2, 2020
Randomized Pragmatic Trial of Stroke Transitional Care: The COMPASS Study
Pamela W Duncan, Cheryl D Bushnell, Sara B Jones, et al.
Nature Chemical Biology
|
April 28, 2015
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre, Kristy G Kuplast, Christina R Majer, et al.
Plos One
|
November 14, 2023
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trial
Tufail Bashir, Marcus Achison, Simon Adamson, et al.
Plos One
|
October 20, 2023
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial
Christos Rossios, Tufail Bashir, Marcus Achison, et al.
Journal of Environmental Quality
|
December 5, 2018
Advancing the Sustainability of US Agriculture through Long-Term Research
P J A Kleinman, S Spiegal, J R Rigby, et al.
Plos One
|
August 2, 2024
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial
Alvin Shrestha, Tufail Bashir, Marcus Achison, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
February 17, 2022
Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial
, Marcus Achison, Simon Adamson, et al.
Page
of 89
Search research articles
Search
Showing results (871-880 of 889) with videos related to
Sort By:
Page
of 89
Cancer Research
|
November 26, 2024
A Potent, Selective, Small-Molecule Inhibitor of DHX9 Abrogates Proliferation of Microsatellite Instable Cancers with Deficient Mismatch Repair
Jennifer Castro, Matthew H Daniels, David Brennan, et al.
Journal of the American Geriatrics Society
|
March 25, 2018
A Person-Centered Approach to Poststroke Care: The COMprehensive Post-Acute Stroke Services Model
Cheryl D Bushnell, Pamela W Duncan, Sarah L Lycan, et al.
Oncotarget
|
April 23, 2016
Abnormal lipid processing but normal long-term repopulation potential of myc-/- hepatocytes
Lia R Edmunds, P Anthony Otero, Lokendra Sharma, et al.
Circulation. Cardiovascular Quality and Outcomes
|
June 2, 2020
Randomized Pragmatic Trial of Stroke Transitional Care: The COMPASS Study
Pamela W Duncan, Cheryl D Bushnell, Sara B Jones, et al.
Nature Chemical Biology
|
April 28, 2015
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Elayne Chan-Penebre, Kristy G Kuplast, Christina R Majer, et al.
Plos One
|
November 14, 2023
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trial
Tufail Bashir, Marcus Achison, Simon Adamson, et al.
Plos One
|
October 20, 2023
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial
Christos Rossios, Tufail Bashir, Marcus Achison, et al.
Journal of Environmental Quality
|
December 5, 2018
Advancing the Sustainability of US Agriculture through Long-Term Research
P J A Kleinman, S Spiegal, J R Rigby, et al.
Plos One
|
August 2, 2024
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial
Alvin Shrestha, Tufail Bashir, Marcus Achison, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
February 17, 2022
Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial
, Marcus Achison, Simon Adamson, et al.
Page
of 89